H-Index
75
Scimago Lab
powered by Scopus
JCR
Clarivate
Analytics
18%
Acceptance
Rate
call: +1.631.470.9640
Mon-Fri 10 am - 2 pm EST

Logo



eISSN: 1643-3750

The systemic inflammatory response predicts overall and cancer specific survival in patients with malignant lymphoma

Maqsood M. Elahi, Donald C. McMillan, Colin S. McArdle, Wilson J. Angerson, Michael Soukop, Jennie Johnstone, Naveed Sattar

Med Sci Monit 2005; 11(2): CR75-78

ID: 14161

Published: 2005-02-01


Background:The value of C-reactive protein concentrations in the assessment of prognosis in patients with advanced lymphoma has not been clearly defined.Material/Methods:Patients with a diagnosis of non-Hodgkin’s lymphoma (n=108) and Hodgkin’s lymphoma, (n=39) and who had measurements of C-reactive protein were studied retrospectively and the data was reviewed over 8 years.Results:Median survival, from the time of sampling, was 7.4 months. On univariate analysis there was a significant relationship between the duration of cancer specific survival and tumour type (p

Keywords: Lymphoma - blood, Lymphoma - complications, Lymphoma - immunology, C-Reactive Protein - metabolism, Female, Humans, Inflammation - immunology, Lymphoma - immunology, Male, Middle Aged, Neoplasm Staging, Prognosis, Survival Rate



Back